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Abstract
Background Data: Transplantation of umbilical cord blood stem cells into damaged
spinal cords was used experimentally for several years. Such transplants survive and
integrate to some degree with the host tissue and may be associated with functional
improvement.
Purpose: To find out the functional improvement, and axon regeneration in spinal
cord injured rats after human umbilical cord blood stem cells (HUCBs) transplantation.
Study Design: Prospective analytic animal experimental study.
Material and Methods: Forty rats were recruited and divided into four groups,
each containing 10 rats: Group (1): Control group with no lesion and intervention.
Group (2): Injured animals with no treatment Group (3): Injured and injected with
saline. Group (4): Injured and injected with HUCBs. Animals were subjected to
behavioral assessment using two physiological tests. Histopathological sections and
immunohistochemical examination were done.
Results: The results of this study have shown that the HUCBs reduced the neurological
function deficit to a moderate degree.
Conclusion: Remyelination and new astrocyte formation could be established after
HUCBs transplantation to the injured rats. (2012ESJ033)
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Introduction
Traumatic spinal cord injury (SCI)
affects many people, especially young,
and can result in severe damage,
leading to paraplegia, tetraplegia,
or quadriplegia. Many strategies,
including surgical, pharmacological,
neurophysiological, and technological
approaches, have been used in

attempts to develop new therapies that
will allow patients to regain use of their
paralyzed limbs. One such strategy is the
transplantation of umbilical cord blood
stem cells into damaged spinal cords,
which has been performed in rats and
cats over the past several years. Such
transplants survive and integrate with
the host tissue and may be associated
with functional improvement.1,12
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Human umbilical cord blood is a valuable source
of cells that have the therapeutic potential to
initiate and maintain tissue repair. This capability
holds special promise for the treatment of neural
diseases, for which no cure is currently available. In
addition, therapies based on human umbilical cord
blood are attractive because the cells are readily
available and less immunogenic as compared to
other source of stem cells, such as bone marrow.
The therapeutic potentials of human umbilical cord
blood may either be attributed to the inherent ability
of stem cell potential of damaged tissue outright,
or alternatively, to their ability to repair damaged
tissue through neural protection and secretion of
neurotrophic factors by various cell types within the
graft.13
There have been many efforts to restores normal
neuronal functions and thus motor functions after
spinal cord injury (SCI), in which the myelin sheaths
and or myelinating cells (e.g. oligodendrocytes)
are destroyed. Although some spontaneous
remyleination occurs, this process is not consistent
enough for complete repair.13 This phenomenon
depends on molecules (e.g., growth factor), most of
which are still unidentified.42
Perhaps more importantly, stem cells could
promote axonal regeneration either by constituting a
“bridge” through a lesion site capable of supporting
attachment and growth or by secreting diffuse
molecules, such as growth factors, to attract injured
axon.23
The focus of this study is to evaluate functional
outcome, and characterize neural differentiation
after transplantation of human cord blood stem cells
into a rodent model of acute spinal cord injury.

Materials and Methods
Separation and culture of HUCBs:
Human umbilical cord blood was obtained,
using sterile syringes, from the umbilical veins
immediately after full-term deliveries. All the
samples were collected after obtaining written
informed consent. The blood sample volume was
100 to 150ml. Aspirated blood was diluted 1:1
with Hank’s balanced salt solution (HBSS) and
centrifuged through a density gradient (FicollPaque Plus; 1.077 g/l; Pharmacia, New York, NY)
at 1000xg for 30 min. The mononuclear cell layer
was then recovered from the gradient interface,
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washed with HBSS, centrifuged at 900xg for 15 min,
and then re-suspended in complete culture medium
[Dulbecco’s modified Eagle medium (DMEM, Gibco
BRL, Carlsbad, CA) supplemented by 20% fetal
bovine serum (Gibco BRL, Carlsbad, CA), 100 units/
ml penicillin, and 100 ug/ml streptomycin], with the
cells at a concentration of 1x106/ml. The cells were
next incubated at 37°C for 3 days.
Animals:
Forty adult (300-350 g) Sprague-Dawley rats from
the Center of experimental animals in Zagazig
University were used in all experimental groups.
All the experiments were performed in compliance
with relevant laws and institutional guidelines.
The procedures followed were in accordance with
the standards set forth in the Guide for the Care
and Use of Laboratory Animals (published by the
National Academy of Science, National Academy
Press, Washington, D.C.). Animals were acclimatized
for one week and kept with free access to standard
pellet animal diet and tap water under controlled
conditions of room temperature.
Spinal cord injury:
Acute SCI was induced using chemical spinal cord
injury by using single intracisternal injection of 0.4
ml 2.5 % Gentamicin sulfate according to the method
of Hodges (Hodges and Watanabe, 1980). Rats were
anesthetized with pentobarbital sodium (50mg/
kg, i.p.). Laminectomy was performed between
T8 and T10 after midline vertical incision over the
thoracic spine then, the paraspinal muscles were
retracted laterally. The dura mater was not opened.
The spinous process was clamped to stabilize the
spine. Injury was induced chemically by using single
intracisternal injection of 0.4 ml 2.5 % Gentamicin
sulfate. After injury, the muscles were closed and
haemeostasis was ensured. Postoperative nursing
care included bladder expression twice a day.
Prophylactic kanamycin (1mg/kg) was regularly
administered for a week.
Study Plan:
Animals were equally divided into four groups, each
containing 10 rats: Group (1): Control group with
no lesion and no intervention. Group (2): Injured
animals with no treatment. Group (3): Injured
animals and injected with saline. Group (4): Injured
animals and injected with stem cells.
Transplantation:
One week after surgery; group 3 animals were
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injected with 5µl normal saline by using insulin
syringe and group 4 animals were injected with total
amount of 1× 106 cells dissolved 5µl saline at the site
of the injured spinal cord.
Behavioral assessment after spinal cord injury (SCI):
1- A behavioral test was performed to measure
functional recovery of the hind limb. The open
field testing procedures used in this study was
described by Basso et al. This scale measures
hind limb movements with a score of 0 indicating
no spontaneous movement, with an increasing
score being given for the use of individual joints,
coordinated joint movement, coordinated limb
movement, weight-bearing and so on to a maximum
score of 21. Behavioral testing was performed weekly
upon each hind limb from the first postoperative day
to 8 weeks after SCI for all animals using the Basso,
Beattie, and Bresnahan locomotor rating scale
(BBB) scoring system, by an independent examiner
who was kept blind regarding the rat’s treatment
status.2,37
2- Inclined plane test (modified Tarlov test).15,39
The device consists of a hinged board raised and
lowered to different angle. The object is for the rate
to maintain itself on the board for 5 seconds as the
angle is gradually increased at 5 degrees intervals.
Uninjured rats achieve approximately 80 degrees.
Histology:
Eight weeks after the induction of injury, the rats
were anesthetized with diethyl ether to sacrifice.
Spinal cords were immediately removed and the
injured region dissected. Segments 20mm rostral
and caudal to the injury site were then embedded
in paraffin. Each block was serially sectioned to
prepare 5 µm thick sections, which were stained
with hematoxylin & eosin (H & E) and Luxol fast blue/
Cresyl violet (LFB/CV) stain. The slides were viewed
under a light microscope to study the structural
changes.
Immunohistochemistry:
For the immunological studies, deparaffinized spinal
cord sections were boiled in citrate buffer (pH 6) for
10 minutes in a microwave oven. Following blocking
in normal serum, the sections were incubated with
monoclonal antibodies Anti-glial fibrillary acidic
protein (GFAP) which is specific for astrocytes in the
central nervous system.
Statistical analysis:
Data was analyzed with the SPSS statistical software
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program version 15.0 (SPSS Inc.) and all summary
statistics for numerical data (quantitative continuous
data) were presented as means± standard deviation
(SD). Result of BBB locomotor and modified Tarlov
inclined plane test were compared between the
studied group with analysis of variance (ANOVA),
followed by post-hoc test. The level of significance
was at (p<0.05).

Results
BBB score:
All rats were evaluated before induction of injury and
all had normal motor function and the score was 21
for all rats (maximum score). After the induction of
injury, rats were evaluated every week to check for
progress (Table 1). There was statistically significant
difference between group 4 and both group 2 and
3. Data was analyzed by post hoc test (scheffe test)
after ANOVA.
The score of group 1 was the same value through
the 8 weeks and this score was used as the baseline
during the observation period (Figure 1). In the first
week, the three injured groups’ score was zero,
indicating a gait characterized by no hind limb weight
bearing and no coordinated hind limb movement,
whereas group 4 score showed consistent plantar
stepping and consistent forelimb-hind limb (FL–HL)
coordination. Toe clearance occurred frequently
during forward limb advancement and predominant
paw position was parallel at initial contact, lift-off
was 16.58± 0.88 which as seen at 8th week. Thus, the
HUCBs transplantation group showed an early and
dramatic improvement in neurological functions
compared with the other control groups (P<0.05).
Inclined Plane Test Score:
All animals were evaluated before injury and
the score was normal (4) for all groups. Progress
was observed every week (Table 2). Stem cells
transplanted group (group 4) showed also early and
dramatic improvement in motor functions compared
with other groups (P<0.05).
Histological Results:
1-Haematoxylin and Eosin Results:
The injured groups (groups 2, 3) sections showed
alterations of white and gray matter which indicated
demylination. It showed spongiosis of white matter
as a result of myelin damage and vacuolation around
axons. It also showed cellular infiltration. In the
gray matter, most neurons showed degenerative or
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2- Luxol Fast Blue/ Cresyl Violet (LFB/CV) Stain
Results:
LFB/CV sections of the injured group revealed
extensive demylination, while sections of stem cells
injected group showed less demylination of the
white matter compared with other groups (Figure
6, 7, 8).
Immunohistochemical results (Anti-GFAP
Immunohistochemical staining):
The injured group showed remarkably increased
anti-GFAP positively stained processes of astrocytes
compared to the control group; with a huge glial
scar extending through the gray matter (Figure 9,
10). Sections of the stem cells treated group showed
less intensely stained cytoplasmic processes of
astrocytes compared to the injured non-treated
group, more or less similar to the control (Figure 11).

necrotic changes, as many neurons were small and
rounded, with pale and/or eosinophilic cytoplasm.
Others showed pyknotic nuclei. Perineuronal
vacuolation and cavitations of the gray matter were
also detected (Figure 3). The condition was more
severe in the saline injected group which showed
extensive vacuolation and necrosis in both gray
matter and white matter, with huge cavitations of
the gray matter (Figure 4). Sections of stem cells
treated group (group 4) also revealed alterations
indicating demylination, but less than detected in
the injured group, as spongiosis of white matter
was less marked and many normally appearing
myelinated fibers were detected. In the gray matter,
normal neurons were seen side by side to small
degenerated neurons with vacuolated cytoplasm
(Figure 5).

Table (1): The Mean Score ± SDV of BBB Sale Rate of all Groups in Every Week
Week

Group1

Group2

Group3

Group4

P value (ANOVA)

1

21±0.000

0.00±0.000

0.22±0.411

0.33±0.500

0.550

2

21±0.000

1.13±0.354

1.11±0.333

4.00±1.118*

0.020*

3

21±0.000

1.29±0.488

1.44±0.527

5.11±1.453*

0.001*

4

21±0.000

1.57±0.537

1.78±0.441

6.89±1.616*

0.000*

5

21±0.000

1.43±0.535

2.25±0.463

8.67±1.732*

0.0008

6

21±0.000

1.71±0.756

2.75±0.463

10.78±1.716*

0.000*

7

21±0.000

2.14±0.690

3.13±0.354

13.33±1.414*

0.000*

8

21±0.000

2.33±0.516

3.50±0.535

16.56±0.882*

0.000*

*P<0.05 statistically significant
Table (2): The Inclined Plane Mean Score ± SDV Results
Weeks

Group1

Group2

Group3

Group4

P-value (ANOVA)

1

4±0.00

0.00±0.000

0.00±0.00

0.56±0.520

0.611

2

4±0.00

0.022±0.441

0.33±0.500

1.22±0.441

0.556

3

4±0.00

0.5±0.535

0.56±0.527

1.78±0.441*

0.015*

4

4±0.00

0.86±0.378

0.67±0.500

2.11±0.601*

0.000*

5

4±0.00

0.86±0.378

1±0.000

2.67±0.500*

0.000*

6

4±0.00

1±0.000

1±0.000

2.86±0.500*

0.000*

7

4±0.00

1±0.000

1±0.000

2.97±0.500*

0.000*

8

4±0.00

1±0.000

1±0.000

3.10±0.441*

0.000*

*P < 0.5
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Figure (1). Hind limb function recovery
after spinal cord injury

Figure (2). inclined plane test result

Figure (3). Spongiosis of white
matter and vacuolation around
axons (v) in the injured untreated
group. It also shows cellular
infiltration (circle) (H&E400)

Figure (4). Huge cavitations
of the gray matter (circles)
saline injected group, with
abnormally shaped neurons &
large perineuronal vacuolation
(asterisk) (H&E400).

F i g u r e ( 5) . Va c u o l a ti o n ,
spongiosis, and cellular infiltration
are less marked in stem cells
treated group. It shows normally
appearing myelinated fibers
(circles). It also shows a normal
neuron (arrow) side by side to
small degenerated neurons with
vacuolated cytoplasm (arrow
heads) (H&E400).

Figure (6). Section in the spinal
cord of a control rat. It shows
the white matter (W) sharply
demarcated from the gray matter
(G) (LFB/CV100).

Figure (7). Section in the spinal
cord of a rat from the injured
untreated group. It shows
extensive demylination (LFB/
CV100).

Figure (8). Section in the spinal
cord of a rat from stem cells treated
group. It shows demylination of
the white matter (W) which is
not sharply demarcated from the
gray matter (G) compared to the
control group (LFB/CV100).
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Figure (9). Section in the spinal
cord of a rat from the control
group. It shows the positively and
intensely stained processes of
astrocytes which appeared brown
in color (arrows) (Anti-GFAP
immunostained400).

F i g u r e (10 ) . Re m a r ka b l y
increased anti-GFAP positively
stained processes in the injured
group with a huge glial scar
extending through the gray
matter (circle) (Anti-GFAP
immunostained100).

Discussion
Cell therapy treatment of cord injury includes cell
substitution for the destroyed spinal cord to enhance
axon regeneration with or without application of
neurotrophic factors to recover the neural tissue.
The neural stem cell has pluripotency to differentiate
into various neural cell types. Human umbilical
cord blood cells (HUCBs) are more pluripotent
and genetically flexible than bone marrow neural
stem cells. They can also be obtained more easily.
It has been reported that stem cells transplanted
into the injured lesion were able to differentiate
into oligodendrocytes and astrocytes and then
integrate into axonal pathways and regenerate and
remyelinate the injured axons.14,21,24,26,27
It has also been reported that HUCBs can be
differentiated into hematological cells and bone
marrow stem cells, and can be replicated and
differentiated into muscle, myocardium, skeletal
cells, hepatocytes, oligocytes, and neurons. 17,
35, 38, 41
For in vitro cultures of HUCBs, there was
differentiation into cells positive for the markers of
NeuN, Neurofilament, MAP-2, GFAP, betatubulin III,
and Gal-C.17,3,6,18,43
In this study, we used HUCB stem cells, since it
provides a rich source and is safe to use, easy to
obtain, and almost not associated with any ethical
issues. Many other cells have been used for the
same purpose such as neural stem cells, embryonic
stem cells and bone marrow stromal cells. However,
neural stem cells are obtained from human fetal
tissue, which raises critical ethical issues. The use of
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Figure (11). Section in the spinal
cord of a rat from the stem
cells treated group. It shows a
picture more or less similar to
that of the control (Anti-GFAP
immunostained400).

embryonic stem cells may entail genetic problems,
including the possibility of tumor formation. With
regard to bone marrow stromal cells, it is difficult
to obtain a large number of cells from bone marrow
because the cells have to be amplified in vitro to
meet the needs of clinical use.31,23,7
In this study, chemically induced cord injury
method described by Hodges et al,20 in 1980 was
used as it causes reproducible and quantified injury.
It requires minimal soft tissue dissection and bone
removal. The procedure can be performed rapidly.
Behavioral and histological data supported that the
animals used in our study developed complete spinal
cord injury. Mechanically induced injury model was
not used as the posterior (dorsal) surface of the
spinal cord receives the traumatic insult, which
may not fully simulate all aspects of pathology of
spinal cord injury. Most patients suffering from SCI
experience a circumferential compression of the
cord, being that forces are acting on both posterior
and anterior aspects.
Motor function was assessed by the BBB scoring
scale described by Basso et al,2 in 1995 and the Tarlov
modified inclined test.15,39 These methods are easy
and the materials can be made locally in comparison
to other methods such as paw compression test and
tail flick tests.
So far; stem cells of human sources grafted into
the injured spinal cord mostly included barely
defined heterogeneous mesenchymal stem cell
populations derived from bone marrow or umbilical
cord blood. Still, reports on functional recovery
are rather inconsistent. While improvement of
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sensory and motor activity was reported in some
studies8,9,19, no recovery was observed in others. 28,
36
Park SI et la,32 (2012) reported that endogenous
cell proliferation and oligogenesis contribute to
functional recovery following spinal cord injury,
after injection of rats with human umbilical cord
blood-derived mesenchymal stem cells.
This study demonstrated that stem cell derived
from HUCB improved functional recovery in rats
after SCI by assessing hind limb motor function
score on the BBB Locomotor Scale2. A significant
recovery of hind limb function was observed in
rats of the stem cells treated group. The BBB
scores improved continuously after 1 week, and
this might be due to continuous axon regeneration
effects of the various neurotrophic factors that
were secreted automatically in combination with
HUCBs transplantation. The neurological motor
function of spinal cord injured rats improved due to
remyelination and regeneration effects of stem cells
on the injured axons, and the neural differentiation
of the transplanted HUCBs.
In this study the mean BBB score was 16.58 ± 0.8
at the end of eight weeks period, which corresponds
to consistent plantar stepping and consistent FL–
HL coordination. Toe clearance occurred frequently
during forward limb advancement; predominant
paw position was parallel at initial contact and
rotated at lift-off. Nishio33 and his group in 2006
reported a score of 9.8 following laminectomy and
after complete spinal transaction. This difference
can be explained by the shorter follow up (5 weeks)
in their study compared to 8 weeks in ours. Similar
results were also obtained by Dasari et al,10 who
found that the HUCB transplanted group improved
8 weeks after injection (BBB score about 15.78 ±
0.5) that may confirm the great role of immediate
treatment after injury.
Inclined plane performance data showed
significant improvement in stem cells treated
group compared with other groups with a score of
3.1±0.41. Teng et al,40 reported a score of 2.99± 0.91
after they used HUCB in hemi-sectioned SCI model.
Overall the inclined plane result mirrored the BBB
scoring confirming that the stem cells involvement
is associated with improvement of motor function.
The histopathological results of the injured
untreated group (group 2) showed that chemical
injury induced myelin damage and vacuolation

10

in the areas of white matter as well as extensive
necrotic changes and irregular cavitations of grey
matter, which appeared atrophic due to neuronal
loss. The remaining neurons were necrotic and
abnormally shaped, with large perineuronal
vacuolation. This was in accordance with Dasari
et al,10 (2007) who stated that spinal cord injury
resulted in loss of tissue, including important
myelinated fiber tracts carrying descending motor
and ascending sensory information. They added
that reduced myelination could result from loss of
myelinating cells and/or reduced myelin synthesis
by surviving oligodendrocytes. The gray matter
in the injured groups of this study showed many
neurons with features characteristic of ischemic
cell death, including cytoplasmic eosinophilia with
disintegration of cytoarchitecture and nuclear
pyknosis.
Anti-GFAP immunostaining of the injured
untreated groups (group 2) showed remarkably
increased anti-GFAP positively stained processes
with a huge glial scar extending through the gray
matter. Upregulation of GFAP expression and
accumulation of glial fibers is the histological
landmark of the astrocyte response to CNS lesion;
appropriately named reactive gliosis.4,16 There is
considerable evidence that implicates the role
of scar-forming astrocytes as inhibitors of axon
regeneration.5,25,33
Animals treated with HUCB cells showed changes
indicating demylination, however, these changes
was less compared to injured non-treated group.
Spongiosis of white matter was less marked and many
normally appearing myelinated fibers were detected.
These findings may indicate partial regenerative
and remyelinating effects of stem cells. John et
al., and McDonald et al,22,24 stated that restoring
myelin through the transplantation of cell therapy
may offer a logical approach to recover optimal
neurological functions. They further explained that
in addition to replacing lost cells, transplantation
appears to modify the host environment to promote
endogenous remyelination. Ning G et al,29 (2013)
found that early transplantation of HUCBs (day 1)
could promote the functional recovery better than
during the subacute phase (day 6). This could be a
further point to explore in following studies.
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Conclusion
We have shown that the HUCBs reduced the
neurological function deficit to a moderate degree
for spinal cord injured rats. Remyelination and new
astrocyte formation could be established after
HUCBs transplantation to the injured rats.
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امللخص العربي
التج��دد العص�بي واالستش��فاء الوظيف��ي بزراع��ة اخلالي��ا اجلذعي��ة م��ن احلب��ل الس��رى البش��رى يف احلب��ل
الش��وكي املص��اب يف فئ��ران التج��ارب
املقدم��ة :تعت�بر إصاب��ات احلب��ل الش��وكي إصاب��ة قد ال تكون فيها رجعة من حيث الضرر الناجم عن كدمات األنس��جة

بس��بب قوة خارجية حادة .وقد مت اس��تخدام زرع اخلاليا اجلذعية املس��تخرجة من دم احلبل الس��ري البش��ري حبقنها يف
احلبل الشوكي التالف على سبيل التجربة لسنوات عدة .وميكن هلذه اخلاليا املزروعة البقاء على قيد احلياة واالندماج
مع النسيج املضيف وقد يرتافق ذلك مع التحسن الوظيفي للحبل الشوكي.
اهل��دف :ته��دف ه��ذه الدراس��ة إىل معرف��ة م��دى التحس��ن الوظيف��ي الناج��م ع��ن حقن اخلالي��ا اجلذعية املس��تخرجة من
احلب��ل الس��ري البش��ري بع��د حقنه��ا يف احلبل الش��وكي التالف يف فئ��ران التجارب.
الط��رق :مت تقس��يم الفئ��ران بالتس��اوي إىل أرب��ع جمموع��ات ،كل جمموع��ة حتت��وي عل��ى  10فئ��ران :جمموع��ة (:)1
اجملموع��ة احلاكم��ة ب��دون إصاب��ة أو تدخ��ل .جمموع��ة ( :)2جمموع��ة مت إج��راء إصاب��ة هل��ا ومل يت��م أي تدخ��ل عالج��ي
حبق��ن اخلالي��ا اجلزعي��ة .جمموع��ة ( :)3مت إج��راء اإلصاب��ة باحلب��ل الش��وكي ث��م حق��ن حمل��ول ملح��ي .جمموع��ة (:)4
مت إج��راء اإلصاب��ة وحق��ن اخلالي��ا البش��رية اجلذعي��ة ل��دم احلب��ل الس��ري .وتعرض��ت احليوان��ات للتقيي��م الس��لوكي
باس��تخدام طريقت�ين م��ن االختب��ارات الفس��يولوجية بع��د اإلصاب��ة ،ث��م القي��ام بفح��ص األنس��جة هس��تولوجياً باس��تخدام
اهليماتوكس��يلني ،يوزي��ن ،واللكس��ول ذو البق��ع الزرق��اء س��ريع ،ومت الفحص املناعي اس��تخدام األجس��ام املض��ادة للربوتني
احلمضي��ة الدبقي��ة ييف��ي (.)GFAP
النتائج :أوضحت الدراسة أن اخلاليا اجلذعية من احلبل السرى البشرى خيفض العجز الوظيفي إىل درجة معتدلة
بالنسبة للفئران املصابني يف النخاع الشوكي.
االس��تنتاج :ميك��ن بذل��ك إثب��ات إمكاني��ة تكوي��ن خالي��ا جنمي��ة جدي��دة فعال��ة بع��د زرع اخلالي��ا اجلذعي��ة يف الفئ��ران
املصاب��ة.
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